 Connection
David Beuther to Surveys and Questionnaires
This is a "connection" page, showing publications David Beuther has written about Surveys and Questionnaires.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.258 |
|
|
|
-
Beuther DA, Murphy KR, Zeiger RS, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Ross M, Coyne KS, Chipps B. The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations. J Allergy Clin Immunol Pract. 2022 Dec; 10(12):3204-3212.e2.
Score: 0.075
-
McCann WA, Chipps BE, Beuther DA, Zeiger RS, Wise RA, George M, Gilbert I, Eudicone JM, Gandhi HN, Cutts K, Harding G, Murphy KR, Reibman J. Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severities. Ann Allergy Asthma Immunol. 2026 06; 136(6):658-664.
Score: 0.024
-
George M, Chipps BE, Beuther DA, McCann W, Reibman J, Wise RA, Zeiger RS, Gilbert I, Eudicone JM, Gandhi HN, Coyne KS, Harding G, Cutts K, Ross M, Murphy KR. What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publications. Ther Adv Respir Dis. 2025 Jan-Dec; 19:17534666251384465.
Score: 0.023
-
Murphy KR, Beuther DA, Chipps BE, Wise RA, McCann WA, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Ross M, Coyne KS, Zeiger RS. Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction Ability. J Allergy Clin Immunol Pract. 2024 Aug; 12(8):2092-2101.e4.
Score: 0.021
-
Chipps BE, Zeiger RS, Beuther DA, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Coyne KS, Harding G, Murphy KR. Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire. Ann Allergy Asthma Immunol. 2024 07; 133(1):49-56.
Score: 0.021
-
McCann W, Murphy KR, Zeiger RS, Beuther DA, Wise RA, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Cutts K, Coyne KS, Chipps B. Assessing meaningful change in the Asthma Impairment and Risk Questionnaire. Ann Allergy Asthma Immunol. 2024 08; 133(2):152-158.
Score: 0.021
-
Wise RA, Chipps B, Murphy KR, Beuther DA, Reibman J, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Cutts K, George M, Zeiger RS. Confirmatory cross-sectional validation of the Asthma Impairment and Risk Questionnaire. J Allergy Clin Immunol Pract. 2023 11; 11(11):3531-3533.e1.
Score: 0.020
-
Chipps B, Zeiger RS, Beuther DA, Reibman J, Wise RA, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Cutts K, George M, Murphy KR. The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control. Ann Allergy Asthma Immunol. 2023 10; 131(4):436-443.e1.
Score: 0.020
-
Chipps BE, Murphy KR, Wise RA, McCann WA, Beuther DA, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Ross M, Zeiger RS. Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall. Ann Allergy Asthma Immunol. 2022 05; 128(5):544-552.e3.
Score: 0.018
-
Murphy KR, Chipps B, Beuther DA, Wise RA, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Coyne KS, Zeiger RS. Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2263-2274.e5.
Score: 0.016
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|